VRTX
Vertex Pharmaceuticals IncorporatedStockHealthcare$451.63−$7.36 (-1.60%)as of Jun 18, 4:00 PM ET
Key stats
- Market cap
- 114.7B
- P/E (ttm)
- 26.4×
- Fwd P/E
- 21.0×
- P/S
- 9.4×
- P/B
- 5.9×
- EPS (ttm)
- $16.85
- EV/EBITDA
- 24.9×
- EV/Sales
- 8.9×
- P/FCF
- 30.9×
- FCF yield
- 3.23%
- Net margin
- 35.51%
- ROE
- 22.41%
- ROA
- 16.38%
- Debt / equity
- 0.01×
- Current ratio
- 3.02
- Beta
- 0.31
- 52W high
- -11.08%
- Rel volume
- 2.21×
- 30D $ vol
- 598.5M
Performance
1D
-1.60%
1W
+1.48%
1M
+3.99%
3M
-1.40%
YTD
-0.11%
1Y
+2.18%
5Y
+133.98%
Financial statements
Open full VRTX financials →Related Healthcare
1MVertex Pharmaceuticals Incorporated (VRTX) trades at $451.63 with a live price and an interactive chart covering 23+ years of daily price history, plus key valuation metrics. ChartRow also publishes VRTX's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full VRTX financial statements →